Device Week Podcast – Episode 3
This article was originally published in The Gray Sheet
This week, "Gray Sheet" reporters and editors discuss our exclusive interview with FDA's Robert Califf and the agency's ongoing efforts to reform combination product regulations, Medicare reimbursements for molecular diagnostic tests, efforts to repeal the medical device tax, earlier than anticipated approval of Edwards Lifesciences' latest transcatheter aortic valve system and more.
You may also be interested in...
Pain relief product sales grew 27% and upper respiratory sales 35% for the week ended 7 March as consumers respond to COVID-19, according to Nielsen data noted in a Jefferies report on consumer health purchasing trends. Private label market share is up slightly, while OTC purchases continue primarily in conventional stores.
Managing partner Corey Goodman said venBio didn’t have trouble closing its fund, because the venture capital firm prepared its investors for an economic downturn months ago.
The US FDA has proposed moving two categories of hepatitis C diagnostics to class II from class III because they pose relatively low risk.